Biomarkers in schizophrenia

被引：7

作者：

Vargas, Gabriel ^{[1
]}

机构：

[1] Amgen Inc, Med Sci, Neurosci Early Dev, Thousand Oaks, CA 91320 USA

来源：

BIOMARKERS IN MEDICINE | 2014年 / 8卷 / 01期

关键词：

biomarkers; schizophrenia; translational; VALIDATION; DIAGNOSIS; IDENTIFICATION; PSYCHIATRY; PSYCHOSIS;

D O I：

10.2217/bmm.13.138

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：1 / 3

页数：3

共 17 条

[1]

Carter MJ, 2014, THER RECREAT J, V48, P275

[2] Research in people with psychosis risk syndrome: a review of the current evidence and future directions [J].

Correll, Christoph U. ;

Hauser, Marta ;

Auther, Andrea M. ;

Cornblatt, Barbara A. .

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2010, 51 (04) :390-431

[3] Integrating ADNI results into Alzheimer's disease drug development programs [J].

Cummings, Jeffrey L. .

NEUROBIOLOGY OF AGING, 2010, 31 (08) :1481-1492

[4] Special issue on CNS experimental medicine [J].

Dawson, Gerard R. ;

Dourish, Colin T. ;

Goodwin, Guy M. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (09) :1145-1147

[5] Validation of experimental medicine methods in psychiatry: The P1 vital approach and experience [J].

Dawson, Gerard R. ;

Craig, Kevin J. ;

Dourish, Colin T. .

BIOCHEMICAL PHARMACOLOGY, 2011, 81 (12) :1435-1441

[6] Precompetitive consortium approach to validation of the next generation of biomarkers in schizophrenia [J].

Dourish, Colin T. ;

Dawson, Gerard R. .

BIOMARKERS IN MEDICINE, 2014, 8 (01) :5-8

[7] Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia [J].

English, Brett A. ;

Thomas, Kelan ;

Johnstone, Jack ;

Bazih, Adam ;

Gertsik, Lev ;

Ereshefsky, Larry .

BIOMARKERS IN MEDICINE, 2014, 8 (01) :29-49

[8] The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients [J].

Guest, Paul C. ;

Chan, Man K. ;

Gottschalk, Michael G. ;

Bahn, Sabine .

BIOMARKERS IN MEDICINE, 2014, 8 (01) :15-27

[9] Current insights into the pathophysiology of Alzheimer's disease: selecting targets for early therapeutic intervention [J].

Hampel, Harald .

INTERNATIONAL PSYCHOGERIATRICS, 2012, 24 :S10-S17

[10] Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? [J].

Kapur, S. ;

Phillips, A. G. ;

Insel, T. R. .

MOLECULAR PSYCHIATRY, 2012, 17 (12) :1174-1179

← 1 2 →